Jacob H. Rand

8.6k total citations · 1 hit paper
125 papers, 5.8k citations indexed

About

Jacob H. Rand is a scholar working on Hematology, Rheumatology and Molecular Biology. According to data from OpenAlex, Jacob H. Rand has authored 125 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Hematology, 43 papers in Rheumatology and 25 papers in Molecular Biology. Recurrent topics in Jacob H. Rand's work include Systemic Lupus Erythematosus Research (43 papers), Platelet Disorders and Treatments (35 papers) and Blood Coagulation and Thrombosis Mechanisms (29 papers). Jacob H. Rand is often cited by papers focused on Systemic Lupus Erythematosus Research (43 papers), Platelet Disorders and Treatments (35 papers) and Blood Coagulation and Thrombosis Mechanisms (29 papers). Jacob H. Rand collaborates with scholars based in United States, Italy and Netherlands. Jacob H. Rand's co-authors include Xiao-Xuan Wu, Philip G. de Groot, Vittorio Pengo, Armando Tripodi, Thomas L. Ortel, Charles J. Lockwood, Mónica Galli, Guido Reber, Seth Guller and Harry A.M. Andree and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Jacob H. Rand

123 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Update of the guidelines for lupus anticoagulant detection

2009 855 citations Vittorio Pengo, Armando Tripodi et al. Journal of Thrombosis and Haemostasis profile →

Peers

Jacob H. Rand

RHEUM

HEMAT

IMMUN

SURGE

Panayiotis G. Vlachoyiannopoulos Greece

Silvia S. Pierangeli United States

G. R. V. Hughes United Kingdom

Gerard Espinosa Spain

María Orietta Borghi Italy

Dario Roccatello Italy

Massimo Cugno Italy

Blaž Rozman Slovenia

T. Papo France

Elisabet Svenungsson Sweden

Panayiotis G. Vlachoyiannopoulos Greece

Jacob H. Rand

5.4k ×1.8

RHEUM

2.4k ×0.8

HEMAT

1.8k ×1.8

IMMUN

643 ×0.8

845 ×1.1

SURGE

Citations per year, relative to Jacob H. Rand Jacob H. Rand (= 1×) peers Panayiotis G. Vlachoyiannopoulos

Countries citing papers authored by Jacob H. Rand

Since Specialization

Citations

This map shows the geographic impact of Jacob H. Rand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob H. Rand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob H. Rand more than expected).

Fields of papers citing papers by Jacob H. Rand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob H. Rand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob H. Rand. The network helps show where Jacob H. Rand may publish in the future.

Co-authorship network of co-authors of Jacob H. Rand

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob H. Rand. A scholar is included among the top collaborators of Jacob H. Rand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob H. Rand. Jacob H. Rand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Devreese, Katrien, Philip G. de Groot, Bas de Laat, et al.. (2020). Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis. Journal of Thrombosis and Haemostasis. 18(11). 2828–2839. 245 indexed citations

Wolgast, Lucia R., et al.. (2017). Reduction of annexin A5 anticoagulant ratio identifies antiphospholipid antibody‐positive patients with adverse clinical outcomes. Journal of Thrombosis and Haemostasis. 15(7). 1412–1421. 9 indexed citations

Bloemen, Saartje, et al.. (2016). Inverted erythrocyte membranes demonstrate β2GPI-antiphospholipid antibody interactions and membrane crosslinking. Thrombosis Research. 146. 89–94. 3 indexed citations

Wu, Yuanyuan, Andrew Nguyen, Michelle N. Vu, et al.. (2014). Antiphospholipid Antibodies Promote Tissue Factor–Dependent Angiogenic Switch and Tumor Progression. American Journal Of Pathology. 184(12). 3359–3375. 7 indexed citations

Arvanitakis, Zoe, Robin L. Brey, Jacob H. Rand, et al.. (2012). Antiphospholipid Antibodies, Brain Infarcts, and Cognitive and Motor Decline in Aging (ABICMA): Design of a Community-Based, Longitudinal, Clinical-Pathological Study. Neuroepidemiology. 40(2). 73–84. 8 indexed citations

Quinn, Anthony S., Jacob H. Rand, Xiao-Xuan Wu, & Douglas J. Taatjes. (2012). Viewing Dynamic Interactions of Proteins and a Model Lipid Membrane with Atomic Force Microscopy. Methods in molecular biology. 931. 259–293. 4 indexed citations

Tiede, Andreas, Jacob H. Rand, Ulrich Budde, Arnold Ganser, & Augusto B. Federici. (2011). How I treat the acquired von Willebrand syndrome. Blood. 117(25). 6777–6785. 182 indexed citations

Hunt, Beverley J., et al.. (2011). Resistance to annexin A5 anticoagulant activity in women with histories for obstetric antiphospholipid syndrome. American Journal of Obstetrics and Gynecology. 205(5). 485.e17–485.e23. 24 indexed citations

Rand, Jacob H., Xiao-Xuan Wu, Anthony S. Quinn, et al.. (2009). Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug. Blood. 115(11). 2292–2299. 191 indexed citations

10.

DeSancho, Maria T., et al.. (2009). Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations. Blood Coagulation & Fibrinolysis. 21(1). 11–15. 6 indexed citations

11.

Collins, Peter W., Ulrich Budde, Jacob H. Rand, A B Federici, & Ch. Kessler. (2008). Epidemiology and general guidelines of the management of acquired haemophilia and von Willebrand syndrome. Haemophilia. 14(s3). 49–55. 45 indexed citations

12.

Eerden, Peter Van, et al.. (2006). Annexin A5 levels in midtrimester amniotic fluid: Association with intrauterine growth restriction. American Journal of Obstetrics and Gynecology. 194(5). 1371–1376. 7 indexed citations

13.

DeSancho, Maria T. & Jacob H. Rand. (2001). BLEEDING AND THROMBOTIC COMPLICATIONS IN CRITICALLY ILL PATIENTS WITH CANCER. Critical Care Clinics. 17(3). 599–622. 19 indexed citations

14.

Rand, Jacob H.. (2000). The pathogenic role of annexin-V in the antiphospholipid syndrome. Current Rheumatology Reports. 2(3). 246–251. 15 indexed citations

15.

Rand, Jacob H.. (2000). Antiphospholipid Antibody-mediated Disruption of the Annexin-V Antithrombotic Shield: a Thrombogenic Mechanism for the Antiphospholipid Syndrome. Journal of Autoimmunity. 15(2). 107–111. 66 indexed citations

16.

Rand, Jacob H., Xiao-Xuan Wu, Seth Guller, et al.. (1997). Antiphospholipid immunoglobulin G antibodies reduce annexin-V levels on syncytiotrophoblast apical membranes and in culture media of placental villi. American Journal of Obstetrics and Gynecology. 177(4). 918–923. 83 indexed citations

17.

Cagnoni, Pablo J., Renato Lenzi, Nathaniel Wisch, Stephanie Seremetis, & Jacob H. Rand. (1995). Spurious fibrinogen levels secondary to pyroglobulinemia in Waldenström's macroglobulinemia. American Journal of Hematology. 48(2). 126–127. 2 indexed citations

18.

Shibata, S, P C Harpel, A E Gharavi, Jacob H. Rand, & Howard Fillit. (1994). Autoantibodies to heparin from patients with antiphospholipid antibody syndrome inhibit formation of antithrombin III-thrombin complexes [see comments]. Blood. 83(9). 2532–2540. 94 indexed citations

19.

Rand, Jacob H., Xiao-Xuan Wu, Seth Guller, et al.. (1994). Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphos pholipid antibodies and recurrent spontaneous abortion. American Journal of Obstetrics and Gynecology. 171(6). 1566–1572. 181 indexed citations

20.

Rand, Jacob H., et al.. (1991). 150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.. Journal of Clinical Investigation. 88(1). 253–259. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact